Galvin Gaustad & Stein’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Galvin Gaustad & Stein's LLY Position: Q3 2026 in Review
Galvin Gaustad & Stein increased its Eli Lilly (LLY) stake by 347% in Q3 2026, buying an estimated $5.6M and bringing the position to 6,115 shares worth $7.08M. The position accounts for 0.53% of the portfolio, ranked #58.
Galvin Gaustad & Stein first reported a position in LLY in Q4 2020 and has held it in 24 quarters since. 1,509 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Galvin Gaustad & Stein held 6,115 shares of Eli Lilly worth $7.08M as of Q3 2026.
- Galvin Gaustad & Stein bought 4,747 Eli Lilly shares in Q3 2026, an estimated $5.6M.
- Eli Lilly made up 0.53% of Galvin Gaustad & Stein's portfolio in Q3 2026, its #58 holding.
- Galvin Gaustad & Stein first reported a position in Eli Lilly in Q4 2020 and has held it in 24 quarters since.
- 1,509 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Galvin Gaustad & Stein's 13F filing for Q3 2026, filed 8 Oct 2026.